Legis Daily

To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.

USA119th CongressHR-1142| House 
| Updated: 2/7/2025
David Schweikert

David Schweikert

Republican Representative

Arizona

Energy and Commerce Committee

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
This bill proposes an amendment to the Public Health Service Act, mandating the Secretary of Health and Human Services to establish comprehensive drug adherence guidelines. The primary objective of these guidelines is to achieve a 90 percent adherence rate for all drugs covered under Medicare Part B and Part D. In developing these guidelines, the Secretary is specifically directed to incorporate advanced artificial intelligence and machine learning technologies . Additionally, the bill emphasizes the importance of promoting the use of generic and biosimilar drugs to the maximum extent feasible within these new adherence protocols.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 7, 2025
Introduced in House
Feb 7, 2025
Referred to the House Committee on Energy and Commerce.
  • February 7, 2025
    Introduced in House


  • February 7, 2025
    Referred to the House Committee on Energy and Commerce.

Health

Advanced technology and technological innovationsMedicarePrescription drugs

To amend the Public Health Service Act to direct the Secretary of Health and Human Services to establish drug adherence guidelines, and for other purposes.

USA119th CongressHR-1142| House 
| Updated: 2/7/2025
This bill proposes an amendment to the Public Health Service Act, mandating the Secretary of Health and Human Services to establish comprehensive drug adherence guidelines. The primary objective of these guidelines is to achieve a 90 percent adherence rate for all drugs covered under Medicare Part B and Part D. In developing these guidelines, the Secretary is specifically directed to incorporate advanced artificial intelligence and machine learning technologies . Additionally, the bill emphasizes the importance of promoting the use of generic and biosimilar drugs to the maximum extent feasible within these new adherence protocols.
View Full Text

Suggested Questions

Get AI-generated questions to help you understand this bill better

Timeline
Feb 7, 2025
Introduced in House
Feb 7, 2025
Referred to the House Committee on Energy and Commerce.
  • February 7, 2025
    Introduced in House


  • February 7, 2025
    Referred to the House Committee on Energy and Commerce.
David Schweikert

David Schweikert

Republican Representative

Arizona

Energy and Commerce Committee

Health

  • Introduced
  • In Committee
  • On Floor
  • Passed Chamber
  • Enacted
Advanced technology and technological innovationsMedicarePrescription drugs